BioOhio, the state’s bioscience membership and development organization, is pleased to announce six additions to its Board of Trustees
. The new trustees are:
- Thomas Boat, M.D., Christian R. Holmes Professor & Dean, College of Medicine Vice President for Health Affairs, University of Cincinnati;
- Frank Douglas, Ph.D., M.D., President & CEO, Austen BioInnovation Institute ;
- Jacob Drapkin, Vice President, Reimbursement & Healthcare Economics, U.S Management Board, Ethicon Endo-Surgery, Inc.;
- John Gorski, President & CEO, NAMSA;
- Jay Mazelsky, Senior Vice President & General Manager, Philips Healthcare;
- Mike Sieron, President & CEO, DG Medical.
They join the following active BioOhio trustees: Chairman John Rice, Ph.D., Managing Partner, Triathlon Medical Ventures ; Vice Chair Caroline Whitacre, Ph.D., Vice President for Research, Office of Research, The Ohio State University; Lisa Ashby, President, Category Management, Cardinal Health; Timothy Biro, Chief Technology Officer, Verium Diagnostics; Greg Blackmore, Chief Operating Officer, Midmark; Mark Collar, Partner, Triathlon Medical Ventures; Anthony Dennis, Ph.D., President & CEO, BioOhio, Inc.; Kevin Driscoll, Ph.D., Executive Director, Global HealthCare R&D, Procter & Gamble Health Care; Brian Duncan, M.D., Venture Partner, Arboretum Ventures & Vice President Business Development, BioEnterprise; Jack Fisher, Executive Vice President of the Ohio Farm Bureau Federation; Michael D. Hooven, President & CEO, Enable Medical Technologies; Peter Kleinhenz, General Partner, CID Equity Partners & Venture Partner, Fletcher Spaght Ventures; Barbara Kunz, President, Health and Life Sciences Global Business, Battelle Memorial Institute; and David Scholl, Ph.D., Retired President, Diagnostic Hybrids, Inc.
BioOhio (formerly Omeris) is a non-profit organization supported by the Thomas Edison Program of the Ohio Department of Development. Its mission is to accelerate bioscience discovery, innovation and commercialization of global value, driving economic growth, and improving quality of life in Ohio. BioOhio is headquartered in Columbus, with regional business development affiliates in Cleveland, Columbus, Cincinnati and Athens.